Provider
2023 March Bulletins
Program effective Date: Mar 01, 2023
Documents & Forms Results
Displaying 1751 - 1760 of 3165 results
Provider
P11-23 Present on Admission Code Required for Hospital Acquired Condition Diagnoses
Program effective Date: Mar 01, 2023
Provider
P69-22 New Medical, Medical Drug, and Behavioral Health Policy Management Updates Effective January 2, 2023
Program effective Date: Mar 01, 2023
Provider
QP112R1-20 Changes to Electronic Funds Transfer Processes
Program effective Date: Feb 22, 2023
Provider
QP11-23 Commercial Pharmacy Benefit Exclusion for Cimzia®
Program effective Date: Feb 22, 2023
Provider
QP12-23 Change in Prior Authorization Process for Experimental or Investigative Services
Program effective Date: Feb 22, 2023
Provider
QP6-23 Commercial Pharmacy Benefit Exclusion for Briumvi™, Hemgenix®, Rebyota™, and Sunlenca® Injection
Program effective Date: Feb 08, 2023
Provider
QP7-23 MHCP Pharmacy Benefit Exclusion for Briumvi™, Hemgenix®, Lunsumio™, Rebyota™, Sunlenca® Injection, and Vivimusta
Program effective Date: Feb 08, 2023
Provider
QP8-23 Commercial Formulary Addition for Growth Hormone Therapeutic Class: Genotropin® (somatropin)
Program effective Date: Feb 08, 2023
Provider
QP9-23 Commercial Pharmacy Benefit Exclusion for Select Medications
Program effective Date: Feb 08, 2023